Physician profile
George E Anderson
NPI 1033102454
$1,865.86
in general payments reported to CMS, 2019-2025
29 companies · $401 in 2025
The $401 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $98.85 · 2021: $74.07 · 2022: $265 · 2023: $138 · 2024: $449 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $281.00 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $234.33 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Biogen, INC. | $168.49 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $142.74 | 2024-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $126.39 | 2022-2025 | |
| Intuitive Surgical, INC. | $108.84 | 2023-2024 | Da Vinci Surgical System |
| Amgen INC. | $97.22 | 2019-2024 | Prolia, Evenity |
| Boston Scientific Corporation | $94.93 | 2019-2025 | Axonics, Upsylon |
| Radius Health, INC. | $90.75 | 2019-2022 | |
| Roche Diagnostics Corporation | $77.41 | 2019 | |
| Evofem Biosciences, INC. | $43.96 | 2020-2022 | |
| Therapeuticsmd, INC. | $42.34 | 2019-2020 | |
| Exeltis, USA INC. | $33.93 | 2022 | |
| Becton, Dickinson and Company | $30.32 | 2025 | Arista |
| Organon LLC | $30.26 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $26.13 | 2019 | |
| Convatec INC. | $22.28 | 2019 | |
| Abbott Laboratories | $22.01 | 2025 | Proclaim |
| Baxter Healthcare | $21.80 | 2024 | Perclot |
| Innovation Technologies INC | $21.69 | 2025 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $21.64 | 2025 | |
| Meditrina | $19.59 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $18.76 | 2024 | |
| Agile Therapeutics, INC. | $17.83 | 2021 | |
| Coopersurgical, INC. | $15.73 | 2025 | Sos |
| Pfizer INC. | $15.44 | 2023 | |
| Novo Nordisk INC | $15.33 | 2024 | |
| Amag Pharmaceuticals, INC. | $13.13 | 2019 | |
| Duchesnay USA Incorporated | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.